P.MOUNIKA, MOHIT KUMAR, KISHOR .M.R, SANJIT, ABISHEK PANDEY
Objective: The present review focus on biotechnology medicines, therapeutic agents obtained from genes, recombinant DNA, developments in protein drug delivery, regulatory aspects of biotechnology-based pharmaceuticals, formulation approaches to protein stabilization, methods used to evaluate protein pharmaceuticals, Production of Biopharmaceuticals from Recombinant DNA Technology. Conclusion: For treatment of disease, therapeutic agents are derived from biotechnology have been approved for human use. Recombinant protein products are developing as a part of pharmaceutical development. The advancement in technology mapping or the genome, explosive growth of the targets identified.